As of Apr 29
| -1.59 / -2.04%|
The 23 analysts offering 12-month price forecasts for St. Jude Medical have a median target of 65.00, with a high estimate of 71.00 and a low estimate of 55.00. The median estimate represents a -14.70% decrease from the last price of 76.20.
The current consensus among 28 polled investment analysts is to Buy stock in St. Jude Medical. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.